Foresight News 消息,据人民财讯报道,翰宇药业与 KuCoin 签署战略合作意向书,双方拟共同探索在香港共同推进中国内地首个以“创新药研发未来收益权”为底层资产的 RWA 代币化试点项目。根据协议,翰宇药业将以其在 GLP-1 类多肽重磅药物领域的技术积累与研发管线为基础资产,KuCoin 则将发挥其在区块链技术、RWA 全流程解决方案和全球合规资源方面的优势,为该项目提供链上映射、资产通证化、交易撮合、收益分配等一体化支持。
Foresight News 消息,据人民财讯报道,翰宇药业与 KuCoin 签署战略合作意向书,双方拟共同探索在香港共同推进中国内地首个以“创新药研发未来收益权”为底层资产的 RWA 代币化试点项目。根据协议,翰宇药业将以其在 GLP-1 类多肽重磅药物领域的技术积累与研发管线为基础资产,KuCoin 则将发挥其在区块链技术、RWA 全流程解决方案和全球合规资源方面的优势,为该项目提供链上映射、资产通证化、交易撮合、收益分配等一体化支持。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.